Table 2 Persons with dementia not otherwise specified (DNOS) living at home
|  | Sweden n = 8 | Finland n = 1 | The NL n = 58 | Germany n = 52 | Estonia n = 42 | France n = 4 | Spain n = 16 | The UK n = 12 |
|---|---|---|---|---|---|---|---|---|
Persons with DNOS, n (%) (total n = 193) | 8 (4) | 1 (1) | 58 (30) | 52 (26) | 42 (21) | 4 (2) | 16 (8) | 12 (6) |
 Age, years; mean (SD) | 86 (6) | 89 (0) | 82 (6) | 84 (6) | 83 (9) | 84 (4) | 90 (7) | 84 (6) |
 Gender, female (%) | 6 (75) | 0 (0) | 32 (55) | 37 (71) | 31 (74) | 3 (75) | 13 (81) | 6 (50) |
 Symptoms, years, mean (SD) | 3.6 (3.7) | 3 (3) | 4.4 (2.7) | 5.1 (3.6) | 5.8 (5.0) | 0.3 (0.5) | 3.5 (2.1) | 4.0 (3.6) |
Comorbidity (CCI), 0–37, mean, (SD) | 2.1 (1.2) | 2.0 (0) | 2.0 (1.3) | 2.8 (1.6) | 2.6 (1.6) | 2.3 (1.9) | 2.6 (1.3) | 1.9 (0.9) |
Cognitive function (SMMSE), 0–30 | 20 (2) | 23 (0) | 14 (6) | 13 (8) | 12 (6) | 14 (7) | 14 (7) | 17 (6) |
Quality of life (QoL-AD), 13–52 | 36 (5) | 27 (0) | 35 (5) | 35 (5) | 28 (7) | – | 34 (3) | 35 (5) |
Activities of daily living (Katz ADL), 0–6 | 4 (2) | 4 (0) | 3 (2) | 2 (2) | 3 (2) | 6 (1) | 2 (2) | 5 (1) |
Depression (CSDD), 0–38, mean (SD) | 8 (8) | 13 (0) | 7 (5) | 11 (6) | 11 (6) | 3 (3) | 10 (7) | 8 (6) |
Resource utilization (RUD) last 30 days (%) | ||||||||
 Hospital admission, geriatric ward | 0 | 0 | 1 (2) | 0 | 0 | 0 | 0 | 0 |
 Visit general practitioner | 3 (38) | 0 | 29 (50) | 42 (81) | 9 (21) | 4 (100) | 7 (44) | 1 (8) |
 Visit geriatrician | 0 | 0 | 4 (7) | 0 | 1 (2) | 0 | 0 | 0 |
 Visit neurologist | 0 | 0 | 0 | 13 (25) | 0 | 0 | 1 (6) | 0 |
 Visit psychiatrist | 0 | 0 | 0 | 0 | 2 (5) | 0 | 0 | 0 |
Neuropsychiatric symptoms (NPI-Q) | ||||||||
 Severity, 0–36, mean, (SD) | 11 (7) | 12 (0) | 10 (7) | 11 (6) | 12 (8) | 5 (5) | 8 (4) | 8 (5) |
Psychotropics, n (%) | 4 (50) | 1 (100) | 1 (47) | 33 (64) | 24 (57) | 2 (50) | 14 (88) | 7 (58) |
 Antipsychotics | 0 | 0 | 13 (22) | 16 (31) | 18 (43) | 0 | 7 (44) | 2 (17) |
 Anxiolytic | 0 | 0 | 7 (12) | 3 (6) | 2 (5) | 2 (50) | 5 (31) | 0 |
 Sedatives | 1 (13) | 1 (100) | 1 (2) | 4 (8) | 4 (10) | 1 (25) | 2 (13) | 0 |
 Antidepressants | 3 (38) | 0 | 4 (7) | 7 (14) | 4 (10) | 2 (50) | 3 (19) | 6 (50) |
 Anti-dementia medictation | 2 (25) | 1 (100) | 10 (17) | 21 (41) | 2 (5) | 0 | 5 (31) | 2 (17) |